Hypertensive heart disease without heart failure
Short Descr | Hypertensive heart disease without heart failure |
Rx-HCC v08 | 187 - Hypertension |
Home Health Clinical Group | MMTA_CARDIAC |
Date
|
Action
|
Notes
|
---|---|---|
2015-10-01 | Added | Code established |
Code
|
Description
|
---|---|
A4644 | SUPPLY OF LOW OSMOLAR CONTRAST MATERIAL (100-199 MGS OF IODINE) [deleted] |
A4645 | SUPPLY OF LOW OSMOLAR CONTRAST MATERIAL (200-299 MGS OF IODINE) [deleted] |
A4646 | SUPPLY OF LOW OSMOLAR CONTRAST MATERIAL (300-399 MGS OF IODINE) [deleted] |
A7030 | Full face mask used with positive airway pressure device, each |
A9512 | Technetium tc-99m pertechnetate, diagnostic, per millicurie |
A9513 | Lutetium lu 177, dotatate, therapeutic, 1 millicurie |
A9514 | SUPPLY OF RADIOPHARMACEUTICAL DIAGNOSTIC IMAGING AGENT, TECHNETIUM TC-99M PYROPHOSPHATE, PER MCI [deleted] |
A9515 | Choline c-11, diagnostic, per study dose up to 20 millicuries |
A9516 | Iodine i-123 sodium iodide, diagnostic, per 100 microcuries, up to 999 microcuries |
A9517 | Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie |
A9519 | SUPPLY OF RADIOPHARMACEUTICAL DIAGNOSTIC IMAGING AGENT, TECHNETIUM TC-99M MACROAGGREGATED ALBUMIN, PER MCI [deleted] |
A9520 | Technetium tc-99m tilmanocept, diagnostic, up to 0.5 millicuries |
A9521 | Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries |
A9522 | SUPPLY OF RADIOPHARMACEUTICAL DIAGNOSTIC IMAGING AGENT, INDIUM-111 IBRITUMOMAB TIUXETAN, PER MCI [deleted] |
A9523 | SUPPLY OF RADIOPHARMACEUTICAL THERAPEUTIC IMAGING AGENT, YTTRIUM 90 IBRITUMOMAB TIUXETAN, PER MCI [deleted] |
A9524 | Iodine i-131 iodinated serum albumin, diagnostic, per 5 microcuries |
A9525 | SUPPLY OF LOW OR ISO-OSMOLAR CONTRAST MATERIAL, 10 MG OF IODINE [deleted] |
A9526 | Nitrogen n-13 ammonia, diagnostic, per study dose, up to 40 millicuries |
A9527 | Iodine i-125, sodium iodide solution, therapeutic, per millicurie |
A9528 | Iodine i-131 sodium iodide capsule(s), diagnostic, per millicurie |
A9529 | Iodine i-131 sodium iodide solution, diagnostic, per millicurie |
A9530 | Iodine i-131 sodium iodide solution, therapeutic, per millicurie |
A9531 | Iodine i-131 sodium iodide, diagnostic, per microcurie (up to 100 microcuries) |
A9532 | Iodine i-125 serum albumin, diagnostic, per 5 microcuries |
A9533 | SUPPLY OF RADIOPHARMACEUTICAL DIAGNOSTIC IMAGING AGENT, I-131 TOSITUMOMAB, PER MILLICURIE [deleted] |
A9534 | SUPPLY OF RADIOPHARMACEUTICAL THERAPEUTIC IMAGING AGENT, I-131 TOSITUMOMAB, PER MILLICURIE [deleted] |
A9535 | INJECTION, METHYLENE BLUE, 1 ML [deleted] |
A9536 | Technetium tc-99m depreotide, diagnostic, per study dose, up to 35 millicuries |
A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
A9538 | Technetium tc-99m pyrophosphate, diagnostic, per study dose, up to 25 millicuries |
A9539 | Technetium tc-99m pentetate, diagnostic, per study dose, up to 25 millicuries |
A9540 | Technetium tc-99m macroaggregated albumin, diagnostic, per study dose, up to 10 millicuries |
A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
A9542 | Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries |
A9543 | Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries |
A9544 | Iodine i-131 tositumomab, diagnostic, per study dose [deleted] |
A9545 | Iodine i-131 tositumomab, therapeutic, per treatment dose [deleted] |
A9546 | Cobalt co-57/58, cyanocobalamin, diagnostic, per study dose, up to 1 microcurie |
A9547 | Indium in-111 oxyquinoline, diagnostic, per 0.5 millicurie |
A9548 | Indium in-111 pentetate, diagnostic, per 0.5 millicurie |
A9549 | TECHNETIUM TC-99M ARCITUMOMAB, DIAGNOSTIC, PER STUDY DOSE, UP TO 25 MILLICURIES [deleted] |
A9550 | Technetium tc-99m sodium gluceptate, diagnostic, per study dose, up to 25 millicurie |
A9551 | Technetium tc-99m succimer, diagnostic, per study dose, up to 10 millicuries |
A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
A9553 | Chromium cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries |
A9554 | Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries |
A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
A9556 | Gallium ga-67 citrate, diagnostic, per millicurie |
A9557 | Technetium tc-99m bicisate, diagnostic, per study dose, up to 25 millicuries |
A9558 | Xenon xe-133 gas, diagnostic, per 10 millicuries |
A9559 | Cobalt co-57 cyanocobalamin, oral, diagnostic, per study dose, up to 1 microcurie |
A9560 | Technetium tc-99m labeled red blood cells, diagnostic, per study dose, up to 30 millicuries |
A9574 | Air polymer-type a intrauterine foam, 0.1 ml |
A9576 | Injection, gadoteridol, (prohance multipack), per ml |
A9577 | Injection, gadobenate dimeglumine (multihance), per ml |
A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml |
A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
C8921 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete |
C8922 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; follow-up or limited study |
C8923 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography |
C8924 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, follow-up or limited study |
C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
C9762 | Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with strain imaging |
C9763 | Cardiac magnetic resonance imaging for morphology and function, quantification of segmental dysfunction; with stress imaging |
C9898 | Radiolabeled product provided during a hospital inpatient stay |
G0010 | Administration of hepatitis b vaccine |
G0027 | Semen analysis; presence and/or motility of sperm excluding huhner |
G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision |
G0124 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician |
G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician |
G0143 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision |
G0144 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system, under physician supervision |
G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
G0147 | Screening cytopathology smears, cervical or vaginal, performed by automated system under physician supervision |
G0148 | Screening cytopathology smears, cervical or vaginal, performed by automated system with manual rescreening |
G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) |
J0151 | Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270) [deleted] |
J0725 | Injection, chorionic gonadotropin, per 1,000 usp units |
J0900 | Injection, testosterone enanthate and estradiol valerate, up to 1 cc [deleted] |
J1000 | Injection, depo-estradiol cypionate, up to 5 mg |
J1060 | Injection, testosterone cypionate and estradiol cypionate, up to 1 ml [deleted] |
J1071 | Injection, testosterone cypionate, 1 mg |
J1094 | Injection, dexamethasone acetate, 1 mg |
J1100 | Injection, dexamethasone sodium phosphate, 1 mg |
J1380 | Injection, estradiol valerate, up to 10 mg |
J1410 | Injection, estrogen conjugated, per 25 mg |
J1620 | Injection, gonadorelin hydrochloride, per 100 mcg |
J2370 | Injection, phenylephrine hcl, up to 1 ml [deleted] |
J2675 | Injection, progesterone, per 50 mg |
J3120 | Injection, testosterone enanthate, up to 100 mg [deleted] |
J3121 | Injection, testosterone enanthate, 1 mg |
J3130 | Injection, testosterone enanthate, up to 200 mg [deleted] |
J3140 | Injection, testosterone suspension, up to 50 mg [deleted] |
J3145 | Injection, testosterone undecanoate, 1 mg |
J3150 | Injection, testosterone propionate, up to 100 mg [deleted] |
J3355 | Injection, urofollitropin, 75 iu |
J7512 | Prednisone, immediate release or delayed release, oral, 1 mg |
J8515 | Cabergoline, oral, 0.25 mg |
J8540 | Dexamethasone, oral, 0.25 mg |
J9202 | Goserelin acetate implant, per 3.6 mg |
J9218 | Leuprolide acetate, per 1 mg |
P3000 | Screening papanicolaou smear, cervical or vaginal, up to three smears, by technician under physician supervision |
P3001 | Screening papanicolaou smear, cervical or vaginal, up to three smears, requiring interpretation by physician |
Q0115 | Post-coital direct, qualitative examinations of vaginal or cervical mucous |
S0122 | Injection, menotropins, 75 iu |
S0126 | Injection, follitropin alfa, 75 iu |
S0128 | Injection, follitropin beta, 75 iu |
S0132 | Injection, ganirelix acetate, 250 mcg |
S0187 | Tamoxifen citrate, oral, 10 mg |
S0265 | Genetic counseling, under physician supervision, each 15 minutes |
S2078 | LAPAROSCOPIC SUPRACERVICAL HYSTERECTOMY (SUBTOTAL HYSTERECTOMY), WITH OR WITHOUT REMOVAL OF TUBE(S), WITH OR WITHOUT REMOVAL OF OVARY(S) [deleted] |
S4011 | In vitro fertilization; including but not limited to identification and incubation of mature oocytes, fertilization with sperm, incubation of embryo(s), and subsequent visualization for determination of development |
S4013 | Complete cycle, gamete intrafallopian transfer (gift), case rate |
S4014 | Complete cycle, zygote intrafallopian transfer (zift), case rate |
S4015 | Complete in vitro fertilization cycle, not otherwise specified, case rate |
S4016 | Frozen in vitro fertilization cycle, case rate |
S4017 | Incomplete cycle, treatment cancelled prior to stimulation, case rate |
S4018 | Frozen embryo transfer procedure cancelled before transfer, case rate |
S4020 | In vitro fertilization procedure cancelled before aspiration, case rate |
S4021 | In vitro fertilization procedure cancelled after aspiration, case rate |
S4022 | Assisted oocyte fertilization, case rate |
S4023 | Donor egg cycle, incomplete, case rate |
S4025 | Donor services for in vitro fertilization (sperm or embryo), case rate |
S4026 | Procurement of donor sperm from sperm bank |
S4028 | Microsurgical epididymal sperm aspiration (mesa) |
S4035 | Stimulated intrauterine insemination (iui), case rate |
S4037 | Cryopreserved embryo transfer, case rate |
S4993 | Contraceptive pills for birth control |
S9560 | Home injectable therapy; hormonal therapy (e.g.; leuprolide, goserelin), including administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
No matching codes found |